Invasive breast carcinoma - IARC

1687. Loman N, Johannsson O,
Kristoffersson U, Olsson H, Borg A (2001).
Family history of breast and ovarian cancers
and BRCA1 and BRCA2 mutations in a
population-based series of early-onset
breast cancer. J Natl Cancer Inst 93: 1215-
1223.
1688. London SJ, Connolly JL, Schnitt SJ,
Colditz GA (1992). A prospective study of
benign breast disease and the risk of
breast cancer. JAMA 267: 941-944.
1689. Longacre TA, Chung MH, Jensen DN,
Hendrickson MR (1995). Proposed criteria
for the diagnosis of well-differentiated
endometrial carcinoma. A diagnostic test
for myoinvasion. Am J Surg Pathol 19: 371-
406.
1690. Longacre TA, Chung MH, Rouse RV,
Hendrickson MR (1996). Atypical polypoid
adenomyofibromas (atypical polypoid adenomyomas)
of the uterus. A clinicopathologic
study of 55 cases. Am J Surg Pathol
20: 1-20.
1691. Longnecker MP (1994). Alcoholic
beverage consumption in relation to risk of
breast cancer: meta-analysis and review.
Cancer Causes Control 5: 73-82.
1692. Longway SR, Lind HM, Haghighi P
(1986). Extraskeletal Ewing's sarcoma arising
in the broad ligament. Arch Pathol Lab
Med 110: 1058-1061.
1693. Longy M, Lacombe D (1996). Cowden
disease. Report of a family and review.
Ann Genet 39: 35-42.
1694. Look KY, Roth LM, Sutton GP (1993).
Vulvar melanoma reconsidered. Cancer 72:
143-146.
1695. Loose JH, Patchefsky AS, Hollander
IJ, Lavin LS, Cooper HS, Katz SM (1992).
Adenomyoepithelioma of the breast. A
spectrum of biologic behavior. Am J Surg
Pathol 16: 868-876.
1 6 9 5 a . Lopes JM, Seruca R, Hall AP,
Branco P, Castedo SM (1990). Cytogenetic
study of a sclerosing stromal tumor of the
ovary. Cancer Genet Cytogenet 49: 103-
106.
1696. Lopez-Rios F, Miguel PS, Bellas C,
Ballestin C, Hernandez L (2000).
Lymphoepithelioma-like carcinoma of the
uterine cervix: a case report studied by in
situ hybridization and polymerase chain
reaction for Epstein-Barr virus. A r c h
Pathol Lab Med 124: 746-747.
1697. Lorenz G (1978). [Adenomatoid tumor
of the ovary and vagina (author's transl)].
Zentralbl Gynakol 100: 1412-1416.
1698. Lorigan PC, Grierson AJ, Goepel JR,
Coleman RE, Goyns MH (1996). Gestational
choriocarcinoma of the ovary diagnosed
by analysis of tumour DNA. Cancer Lett
104: 27-30.
1699. Lorincz AT, Reid R, Jenson AB,
Greenberg MD, Lancaster W, Kurman RJ
(1992). Human papillomavirus infection of
the cervix: relative risk associations of 15
common anogenital types. Obstet Gynecol
79: 328-337.
1700. Losi L., Lorenzini R., Eusebi V,
Bussolati G (1995). Apocrine differentiation
in invasive carcinoma of the breast. Appl
Immunohistochem 3: 91-98.
1701. Lotocki RJ, Krepart GV, Paraskevas
M, Vadas G, Heywood M, Fung FK (1992).
Glassy cell carcinoma of the cervix: a
bimodal treatment strategy. G y n e c o l
Oncol 44: 254-259.
1702. Loverro G, Cormio G, Renzulli G,
Lepera A, Ricco R, Selvaggi L (1997).
Serous papillary cystadenoma of borderline
malignancy of the broad ligament. Eur
J Obstet Gynecol Reprod Biol 74: 211-213.
1703. Loy TS, Calaluce RD, Keeney GL
(1996). Cytokeratin immunostaining in differentiating
primary ovarian carcinoma
from metastatic colonic adenocarcinoma.
Mod Pathol 9: 1040-1044.
1704. Lu KH, Cramer DW, Muto MG, Li EY,
Niloff J, Mok SC (1999). A populationbased
study of BRCA1 and BRCA2 mutations
in Jewish women with epithelial
ovarian cancer. Obstet Gynecol 93: 34-37.
1705. Lu SL, Kawabata M, Imamura T,
Akiyama Y, Nomizu T, Miyazono K, Yuasa Y
(1998). HNPCC associated with germline
mutation in the TGF-beta type II receptor
gene. Nat Genet 19: 17-18.
1706. Lu X, Nikaido T, Toki T, Zhai YL, Kita
N, Konishi I, Fujii S (2000). Loss of heterozygosity
among tumor suppressor
genes in invasive and in situ carcinoma of
the uterine cervix. Int J Gynecol Cancer 10:
452-458.
1707. Lu YJ, Osin P, Lakhani SR, Di Palma S,
Gusterson BA, Shipley JM (1998).
Comparative genomic hybridization analysis
of lobular carcinoma in situ and atypical
lobular hyperplasia and potential roles
for gains and losses of genetic material in
breast neoplasia. Cancer Res 58: 4721-
4727.
1708. Lucas FV, Perez-Mesa C (1978).
Inflammatory carcinoma of the breast.
Cancer 41: 1595-1605.
1709. Luchtrath H, Moll R (1989).
Mucoepidermoid mammary carcinoma.
Immunohistochemical and biochemical
analyses of intermediate filaments.
Virchows Arch A Pathol Anat Histopathol
416: 105-113.
1710. Ludwig T, Chapman DL, Papaioannou
VE, Efstratiadis A (1997). Targeted mutations
of breast cancer susceptibility gene
homologs in mice: lethal phenotypes of
Brca1, Brca2, Brca1/Brca2, Brca1/p53, and
Brca2/p53 nullizygous embryos. G e n e s
Dev 11: 1226-1241.
1711. Luevano-Flores E, Sotelo J, Tena-
Suck M (1985). Glial polyp (glioma) of the
uterine cervix, report of a case with
demonstration of glial fibrillary acidic protein.
Gynecol Oncol 21: 385-390.
1712. Luft F, Gebert J, Schneider A,
Melsheimer P, von Knebel DM (1999).
Frequent allelic imbalance of tumor suppressor
gene loci in cervical dysplasia. Int
J Gynecol Pathol 18: 374-380.
1713. Lui M, Dahlstrom JE, Bell S, James
DT (2001). Apocrine adenoma of the breast:
diagnosis on large core needle biopsy.
Pathology 33: 149-152.
1714. Lukas C, Bartkova J, Latella L, Falck
J, Mailand N, Schroeder T, Sehested M,
Lukas J, Bartek J (2001). DNA damageactivated
kinase Chk2 is independent of
proliferation or differentiation yet correlates
with tissue biology. Cancer Res 61:
4990-4993.
1715. Luna-More S, Gonzalez B, Acedo C,
Rodrigo I, Luna C (1994). Invasive
micropapillary carcinoma of the breast. A
new special type of invasive mammary
carcinoma. Pathol Res Pract 190: 668-674.
1716. Lund B, Thomsen HK, Olsen J (1991).
Reproducibility of histopathological evaluation
in epithelial ovarian carcinoma.
Clinical implications. APMIS 99: 353-358.
1717. Lurain JR, Brewer JI, Torok EE,
Halpern B (1982). Gestational trophoblastic
disease: treatment results at the Brewer
Trophoblastic Disease Center. O b s t e t
Gynecol 60: 354-360.
1718. Luton JP, Clerc J, Paoli V, Bonnin A,
Dumez Y, Vacher-Lavenu MC (1991).
[Bilateral Leydig cell tumor of the ovary in
a woman with congenital adrenal hyperplasia.
The first reported case]. Presse
Med 20: 109-112.
1 7 1 9 . Luttges JE, Lubke M (1994).
Recurrent benign Mullerian papilloma of
the vagina. Immunohistological findings
and histogenesis. Arch Gynecol Obstet
255: 157-160.
1720. Luxman D, Jossiphov J, Cohen JR,
Wolf Y, David MP (1997). Uterine metastasis
from vulvar malignant melanoma. A
case report. J Reprod Med 42: 244-246.
1721. Luzzi V, Holtschlag V, Watson MA
(2001). Expression profiling of ductal carcinoma
in situ by laser capture microdissection
and high-density oligonucleotide
arrays. Am J Pathol 158: 2005-2010.
1722. Lyday RO (1952). Fibroma of the ovary
with abdominal implants. Am J Surg 84:
737-738.
1723. Lynch ED, Ostermeyer EA, Lee MK,
Arena JF, Ji H, Dann J, Swisshelm K,
Suchard D, MacLeod PM, Kvinnsland S,
Gjertsen BT, Heimdal K, Lubs H, Moller P,
King MC (1997). Inherited mutations in
PTEN that are associated with breast can -
cer, cowden disease, and juvenile polyposis.
Am J Hum Genet 61: 1254-1260.
1724. Lynch HT, Albano WA, Heieck JJ,
Mulcahy GM, Lynch JF, Layton MA, Danes
BS (1984). Genetics, biomarkers, and control
of breast cancer: a review. Cancer
Genet Cytogenet 13: 43-92.
1725. Lynch HT, de la Chapelle A (1999).
Genetic susceptibility to non-polyposis
colorectal cancer. J Med Genet 36: 801-
818.
1726. Mabuchi K, Bross DS, Kessler II
(1985). Risk factors for male breast cancer.
J Natl Cancer Inst 74: 371-375.
1727. MacLachlan TK, Somasundaram K,
Sgagias M, Shifman Y, Muschel RJ, Cowan
KH, El Deiry WS (2000). BRCA1 effects on
the cell cycle and the DNA damage
response are linked to altered gene
expression. J Biol Chem 275: 2777-2785.
1728. MacSweeney JE, King DM (1994).
Computed tomography, diagnosis, staging
and follow-up of pure granulosa cell
tumour of the ovary. Clin Radiol 49: 241-245.
1729. Madison T, Schottenfeld D, Baker V
(1998). Cancer of the corpus uteri in white
and black women in Michigan, 1985-1994:
an analysis of trends in incidence and mortality
and their relation to histologic subtype
and stage. Cancer 83: 1546-1554.
1730. Maehama T, Dixon JE (1998). The
tumor suppressor, PTEN/MMAC1, dephosphorylates
the lipid second messenger,
phosphatidylinositol 3,4,5-trisphosphate. J
Biol Chem 273: 13375-13378.
1731. Magi-Galluzi C, O'Connor JT, Neffen
F, Sun D, Quade BJ, Crum CP, Nucci MR
(2001). Are mucinous cystadenomas of the
ovary derived from germ cells ? M o d
Pathol 14: 140 A.
1732. Magrina JF, Gonzalez-Bosquet J,
Weaver AL, Gaffey TA, Leslie KO, Webb
MJ, Podratz KC (2000). Squamous cell car -
cinoma of the vulva stage IA: long-term
results. Gynecol Oncol 76: 24-27.
1733. Magro G, Bisceglia M, Michal M
(2000). Expression of steroid hormone
receptors, their regulated proteins, and
bcl-2 protein in myofibroblastoma of the
breast. Histopathology 36: 515-521.
1734. Magro G, Fraggetta F, Torrisi A,
Emmanuele C, Lanzafame S (1999).
Myofibroblastoma of the breast with
hemangiopericytoma-like pattern and
pleomorphic lipoma-like areas. Report of a
case with diagnostic and histogenetic
considerations. Pathol Res Pract 195: 257-
262.
1735. Magro G, Michal M, Bisceglia M
(2001). Benign spindle cell tumors of the
mammary stroma: diagnostic criteria, classification,
and histogenesis. Pathol Res
Pract 197: 453-466.
1736. Magro G, Michal M, Vasquez E,
Bisceglia M (2000). Lipomatous myofibroblastoma:
a potential diagnostic pitfall in the
spectrum of the spindle cell lesions of the
breast. Virchows Arch 437: 540-544.
1737. Mahmoud-Ahmed AS, Suh JH,
Barnett GH, Webster KD, Kennedy AW
(2001). Tumor distribution and survival in
six patients with brain metastases from
cervical carcinoma. Gynecol Oncol 8 1 :
196-200.
1738. Mai KT, Yazdi HM, Bertrand MA,
LeSaux N, Cathcart LL (1996). Bilateral primary
ovarian squamous cell carcinoma
associated with human papilloma virus
infection and vulvar and cervical intraepithelial
neoplasia. A case report with
review of the literature. Am J Surg Pathol
20: 767-772.
1739. Maier RC, Norris HJ (1980).
Coexistence of cervical intraepithelial neoplasia
with primary adenocarcinoma of the
endocervix. Obstet Gynecol 56: 361-364.
1740. Maier WP, Rosemond GP, Goldman
LI, Kaplan GF, Tyson RR (1977). A ten year
study of medullary carcinoma of the
breast. Surg Gynecol Obstet 144: 695-698.
1741. Maiorano E, Ricco R, Virgintino D, et
al. (1994). Infiltrating myoepithelioma of the
breast. Appl Immunohistochem 2: 130-136.
1742. Maitra A, Wistuba II, Gibbons D,
Gazdar AF, Albores-Saavedra J (1999).
Allelic losses at chromosome 3p are seen
in human papilloma virus 16 associated
transitional cell carcinoma of the cervix.
Gynecol Oncol 74: 361-368.
1743. Maitra A, Wistuba II, Washington C,
Virmani AK, Ashfaq R, Milchgrub S, Gazdar
AF, Minna JD (2001). High-resolution chromosome
3p allelotyping of breast carcinomas
and precursor lesions demonstrates
frequent loss of heterozygosity and a discontinuous
pattern of allele loss. Am J
Pathol 159: 119-130.
1744. Majmudar B, Ross RJ, Gorelkin L
(1979). Benign blue nevus of the uterine
cervix. Am J Obstet Gynecol 134: 600-601.
1745. Major FJ, Blessing JA, Silverberg SG,
Morrow CP, Creasman WT, Currie JL,
Yordan E, Brady MF (1993). Prognostic factors
in early-stage uterine sarcoma. A
Gynecologic Oncology Group study.
Cancer 71: 1702-1709.
1746. Malik SN, Wilkinson EJ (1999).
Pseudo-Paget's disease of the vulva: a
case report. J Lower Genital Tract Disease
3: 201-203.
1747. Malinak LR, Miller GV, Armstrong JT
(1966). Primary squamous cell carcinoma
of the Fallopian tube. Am J Obstet Gynecol
95: 1167-1168.
1748. Mallory SB (1995). Cowden syndrome
(multiple hamartoma syndrome). Dermatol
Clin 13: 27-31.
1749. Malmstrom H, Janson H, Simonsen E,
Stenson S, Stendahl U (1990). Prognostic
factors in invasive squamous cell carcinoma
of the vulva treated with surgery and
irradiation. Acta Oncol 29: 915-919.
References 399